Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
In summary, available data demonstrate that IL-1 and TNF are the causative agents underlying the bone loss induced by estrogen deficiency. Indeed, these factors are produced in bone and the bone marrow, released in larger amounts from cells of estrogen-deficient subjects, and indispensable for reproducing the effects of estrogen deficiency in bone. These observations support the hypothesis that the bone sparing effect of estrogen is due to the ability of the hormone to block osteoclastogenesis, the activation of mature osteoclasts and, as recently demonstrated, the rate of apoptotic osteoclast death. Although IL-1 and TNF play a prominent causal role in these events, the bone-sparing effect of estrogen is mediated by numerous cytokines which, by simultaneously stimulating multiple target cells, induce effects that are not accounted for by any one single factor (Fig. 2). The ability of estrogen to regulate some, but not all, the cytokines involved in this process is not inconsistent with this hypothesis because cytokines have potent synergistic effects. Thus, a considerable increase in bone resorption may result from a relatively small increase in the concentration of only a few of the bone-resorbing factors present in the bone microenvironment. This concept is best illustrated by the study of Miyaura et al. demonstrating that the concentrations of either IL-1, IL-6, IL-6 receptor, or prostaglandins detected in the bone marrow of OVX mice are insufficient to account for the increased bone resorption caused by estrogen withdrawal. In contrast, the increase in bone resorption induced by OVX can be explained by the cumulative effects of these cytokines. Thus, a better understanding of the cooperative effects of cytokines and a recognition that the contribution of individual cytokines to postmenopausal bone loss varies with the passage of time after menopause are necessary to fully understand the mechanism of action of estrogen in bone. Although the relevance of individual bone-targeting cytokines in species specific, the development of transgenic mice with activatable or deactivatable promoters is likely to result in a further clarification of the integrated action of estrogen-regulated cytokines in human bone cells and lay the foundations for the use of cytokine inhibitors in the treatment of postmenopausal osteoporosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Estrogen acts via suppression of bone resorption [43–45]”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [44]
In the citing paper
“In addition, estrogen inhibits osteoclast formation by reducing the levels of other osteoclastogenic cytokines such as IL-1, IL-6, IL-11, TNF-α, TNF-β, and M-CSF [160, 161].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [160]
Citations
Cites
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,040
An interleukin 1 like factor stimulates bone resorption in vitro
Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. B., & Russell, R. G. G. (1983) · Nature · doi:10.1038/306378a0 · Cited by 1,012
Modulation of Osteoclast Differentiation
SUDA, T., TAKAHASHI, N., & MARTIN, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004 · cited 2×
“(22) These mice, which are cured by the administration of M-CSF,(3s) have an extra thymidine inserted within the coding region of the M-CSF gene, a mutation that generates a stop codon within the coding sequence,(3h) thereby resulting in the production of a defective M-CSF.(22) The formation of osteoclasts in bone mar…”
BackgroundSoluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
TURNER, R. T., RIGGS, B. L., & SPELSBERG, T. C. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-275 · Cited by 754
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749
Research works printed but not linked: 11
- Srivastava, 1995, Estrogen down-regulates the expression of M-CSF mRNA in bone marrow stromal cells by stimulating the production of the transcription factor EGR-1, J Bone Miner Res, 10, S18
- Matayoshi, 1995, Generation of human osteoclasts from peripheral blood cd 34+ cells, J Bone Miner Res, 10
- Pacifici, 1990, TNFα and GM-CSF secretion from human blood monocytes: Effect of menopause and estrogen replacement, J Bone Miner Res, 5, 145
- Kimble, 1996, Estrogen inhibits IL-1 and TNF gene expression in transfected murine macrophagic cells, J Bone Miner Res, 11
- Kaneki, 1991, The effect of menopause on IL-1 and IL-6 release from peripheral blood monocytes, J Bone Miner Res, 6, 76
- Thompson, 1991, IL-lra: Properties and uses of an interleukin-1 receptor antagonist, Agents Actions, 41
- Girasole, 1995, Increased serum soluble interleukin-6 receptor levels are induced by ovariectomy, prevented by estrogen replacement, and reversed by alendronate administration, J Bone Miner Res, 10, A86
- McKane, 1993, Effect of age and menopause on serum interleukin-1β and intereleukin-6- levels in women, J Bone Miner Res, 8, 162A
- Kimble, 1994, Long-term treatment with IL-1 receptor antagonist (IL-lra) blocks bone loss in ovariectomized rats, J Bone Miner Res, 9, B380
- Kimble, 1995, Inhibition of IL-6 activity is genetically normal mice does not prevent ovariectomy-induced bone loss, J Bone Miner Res, 10, s160
- Ammann, 1995, Transgenic mice expressing high levels of soluble tumor necrosis factor receptor-1 fusion protein are protected from bone loss caused by estrogen deficiency, J Bone Miner Res, 10
Cited by
Items 601–700 of 743
Trentacosta, N. E., Kaneda, G., Schimmoeller, N. R., Huang, D. T., Galloway, J., Fisher, M., Castaneda, C. M., Blough, C. L., Kremen, T. J., Cc, J., et al. (2026) · Sports Health A Multidisciplinary Approach · doi:10.1177/19417381261459590 · Cited by 2
“43,51 IL-1 β and TNF-α were also correlated with risk of injury in female athletes.”
Chitosan based bionanocomposites in osteoporosis
Niranjan, M. K., Baghel, K., & Azam, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821280-6.00014-3 · Cited by 2
The Impact of Women’s Oral Health on Systemic Health
Haskin, C., & Mobley, C. C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00100-x · Cited by 2
Rahnama, M., Tomaszewski, T., & Świątkowski, W. (2002) · Cited by 2
Effects of Aging on Bone Structure and Metabolism
Pacifici, R., & Avioli, L. V. (2000) · Elsevier eBooks · doi:10.1016/b978-012068705-3/50003-6 · Cited by 2
Self-citationPathophysiology and Aging of Bone
Pietschmann, P., Gruber, R., & Peterlik, M. (2008) · Medical radiology · doi:10.1007/978-3-540-68604-0_2 · Cited by 3
Faria, M. A., Simões, R. S., dos Santos, M. A., Soares, J. M., & Carbonel, A. A. F. (2013) · Reprodução & Climatério · doi:10.1016/j.recli.2013.03.005 · Cited by 4
Esteroides sexuales y hueso: ¿tiene sexo el hueso?
Fernández, E. G., Iglesias, S. G., Salinas, H. R., Gimeno, E. J., & Carranza, F. H. (2005) · Revista Española de Enfermedades Metabólicas Óseas · doi:10.1016/s1132-8460(05)72668-4 · Cited by 3
Lee, H., Lee, T.-H., Kim, J.-H., Seok, J., Lee, S., Kim, Y., Kim, J.-E., Chung, M.-J., & Yeo, M.-H. (2010) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · Cited by 2
Clinical Disorders Associated with Alterations in Bone Resorption
Rubin, J. E., & Nanes, M. S. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_7 · Cited by 2
“controversy [73, 85].”
Oury, F. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415784-2.00011-7 · Cited by 2
The Role of Sex Steroids in the Effects of Immune System on Bone
Grčević, D., Kovačić, N., & Lee, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00012-8 · Cited by 2
Menopause and Hormone Replacement Therapy
Mahajan, S. T., Pinto, A., & Williams, D. B. (2002) · CRC Press eBooks · doi:10.3109/9780203908938-27 · Cited by 2
Assessment of periodontal status of postmenopausal women attending dental clinics
Bhat, S. P., Saloda, N., Bhat, N., & Saloda, N. (2017) · International Journal of Recent Scientific Research · doi:10.24327/ijrsr.2017.0803.0072 · Cited by 3
“…tumour necrosis factor - alpha, granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor, which stimulates mature osteoclasts, modulates bone cell proliferation, and induces resorption of both skeletal and alveolar bone (Pacifici, 1996; Pacifici et al, 1991).”
BackgroundThe Effect of Smoking on Bone Health
Kim, K. H. (2013) · Journal of the Korean Society for Research on Nicotine and Tobacco · doi:10.25055/jksrnt.2013.4.1.20 · Cited by 2
“여성호르몬인 에스트로겐은 골대사에서 주로 골흡수를 억제하여 뼈를 보호하는 역할을 한다고 알려져 있다.(49) 에 스트로겐 저하로 인한 골다공증은 폐경여성 뿐 아니라 남성”
Integrative computational approach to evaluate risk genes for postmenopausal osteoporosis
Sheng, Y., Tang, J., Ren, K., Manor, L. C., & Cao, H. (2018) · IET Systems Biology · doi:10.1049/iet-syb.2017.0043 · Cited by 2
“In addition, 9 pathways/groups were related to cell growth and proliferation (51 unique genes) [12]; 7 to drug effects (49 unique genes) [13], 4 to cell apoptosis (31 unique genes) [14, 15]; 4 to transcription factors (38 unique genes) [16, 17]; 2 to protein phosphorylation (16 unique genes) [18];…”
Sclerostin Modulation Holds Promise for Dental Indications
Hassan, M. G., Zaher, A. R., Palomo, J. M., & Palomo, L. (2018) · Healthcare · doi:10.3390/healthcare6040134 · Cited by 2
“Bisphosphonates reduce net bone loss related to high bone turnover rates by interfering with osteoclasts [2,5].”
BackgroundThe application of laparoscopy in abdominal trauma at Al-Jumhoori Teaching Hospital in Mosul
Asaad, M., Al-Dabbagh, K. A., Ali, M. S., Attash, S. M., & Al-Khyatt, M. K. (2012) · Annals of the College of Medicine Mosul/Annals of the College of Medecine · doi:10.33899/mmed.2012.64399 · Cited by 2
The Role of Osteoporosis in Hip Fractures in Two Italian Hospitals
Ricciardi, A., Geraci, A., Montagner, I. M., Domenico, A. G., Luca, M., & Corso, L. (2016) · SM Journal of Orthopedics · doi:10.36876/smjo.1045 · Cited by 2
“Possible explanations include reduced osteoblast lifespan, increased osteoclast lifespan, abnormal osteocyte signalling or a physiological response to inactivity in old age [18].”
BackgroundPostmenopausal Osteoporosis: Pathogenesis, Diagnosis, and Treatment
Jackson, R. D. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-246-3_4 · Cited by 2
Regulation of Bone Cell Function by Estrogens
Komm, B. S., Cheskis, B. J., & Bodine, P. V. N. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50015-9 · Cited by 2
Cohen-Solal, M. E., Court, C., Morieux, C., Graulet, A. M., Sedel, L., Kuntz, D., de Vernejoul, M. C., & Meunier, A. (1998) · Calcified Tissue International · doi:10.1007/s002239900386 · Cited by 2
“They have also been implicated in the pathogenesis of bone loss in various bone diseases, including osteoporosis [14, 15].”
BackgroundRubin, C. D. (1999) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199909000-00011 · Cited by 3
The role of TRPV4 in osteogenesis and cell signaling in MC3T3-E1 ostoeoblast-like cells
Howell, K. (2012) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/kfc5-9953 · Cited by 2
Liu, D. (2000) · VTechWorks (Virginia Tech) · Cited by 4
Mechanisms of Estrogen Action in Bone
Pacifici, R. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50141-4 · Cited by 6
Self-citationGallagher, J. C., & Rapuri, P. B. (2003) · Elsevier eBooks · doi:10.1016/b0-12-341103-3/00225-4 · Cited by 2
Sebastián Rivera, R., Muñoz, C. S., Deborah Morales, S., Tatiana Núñez, R., & Parra, F. E. (2019) · Revista de otorrinolaringología y cirugía de cabeza y cuello · doi:10.4067/s0718-48162019000100033 · Cited by 1
Ma, Y., Liu, Y., Hai, L., Kailun, Y., & Yao, G. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1503117 · Cited by 1
Jin, M., & Yoo, W. S. (2025) · Journal of Bone Metabolism · doi:10.11005/jbm.25.869 · Cited by 1
Chandel, R., Wankhede, A. N., Reche, A. R., Paul, P., Rakhunde, P. M., & Dalal, A. M. (2026) · Multidisciplinary Science Journal · doi:10.31893/multiscience.2026534 · Cited by 1
Qin, Z., Liao, J., Peng, X., Teng, Y., Wan, B., & Zong, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1950298 · Cited by 1
“Furthermore, estrogen plays a role in promoting apoptosis of osteoclasts and inhibiting apoptosis of osteoblasts (4, 10).”
Dietary Fatty Acids and Inflammatory Disease
Fernandes, G. (2006) · AOCS Publishing eBooks · doi:10.1201/9781439822418.pt4 · Cited by 2
The Role of Functional Foods and Their Bioactive Components in Bone Health
Arjmandi, B. H., & Johnson, S. (2015) · Healthy ageing and longevity · doi:10.1007/978-3-319-14830-4_8 · Cited by 1
“Postmenopausal osteoporosis is the most common cause of bone loss and occurs, in part, due to an abrupt cessation of ovarian hormone production which leads to an imbalance between bone resorption and bone formation [3, 4].”
BackgroundManolagas, S. C. (2002) · BoneKEy-Osteovision · doi:10.1138/2002012 · Cited by 1
Identification of genes for complex diseases by integrating multiple types of genomic data
Cao, H., Lei, S., Deng, H., & Wang, Y. (2012) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2012.6347249 · Cited by 1
Risk Factors for Low Bone Mineral Density in Korean Patients with Systemic Lupus Erythematosus
Park, Y., Park, B.-H., Min, D., & Kim, W. (2011) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2011.18.1.19 · Cited by 1
“이외 에도 에스트로겐의 감소, 칼슘섭취나 비타민 D의 부족, 육 체적 활동이나 체중의 감소, 흡연 및 만성적 당질코르티코 이드 사용 등과 같은 조절 가능한 위험인자들도 골다공증 발생에서 중요한 역할을 한다 (9-14).”
Expression of osteoclastogenesis related factors in dental implant patients
Ryu, S. H., Kim, B.-S., Jung, S., Han, M.-S., Kook, M.-S., Ohk, S., Oh, H.-K., & Park, H. J. (2010) · 대한구강악안면외과학회지 · doi:10.5125/jkaoms.2010.36.5.386 · Cited by 1
Gosselin, J., Bougnères, C., Bennet, P., Avenel, G., Vittecoq, O., & Daragon, A. (2015) · Revue du Rhumatisme · doi:10.1016/j.rhum.2015.01.001 · Cited by 1
“31 Au niveau tissulaire, l’augmentation d’activité des ostéoclastes entraîne une augmentation de la résorption osseuse et entraîne la perforation des travées osseuses ce qui diminue la résistance mécanique du tissu osseux [39].”
BackgroundMenopausal syndrome in female patients with rheumatoid arthritis
Nagamine, R., Maeda, T., Shuto, T., Nakashima, Y., Hirata, G., & Iwamoto, Y. (2001) · Modern Rheumatology · doi:10.3109/s101650170009 · Cited by 1
“Estrogen regulates the production of inflammatory cytokines such as IL-1, IL-6, and TNFα, and it has been proved that these inflammatory cytokines are produced in greater abundance in conditions of estrogen deficiency.(7) Horai et al.”
Association of tumor necrosis factor receptor 1 gene polymorphism with bone mineral density
Hoshino, S., Hosoi, T., Shiraki, M., Orimo, H., Ouchi, Y., & Inoue, S. (2003) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1046/j.1444-1586.2003.00065.x · Cited by 1
Biochemische Marker des Knochenstoffwechsels nach Osteotomie Das Schaf als Osteoporosemodell
der Ludwig-Maximilians-Universität, F., & Rambeck, W. A. (2007) · Cited by 1
L'effet des oestrogènes dans l'os : une histoire de famille.
Vanacker, J.-M., Bonnelye, E., Fournier, B., & Laudet, V. (1999) · médecine/sciences · doi:10.4267/10608/1383 · Cited by 5
“Sur les ostéoblastes, les œstrogènes induisent, d’une part, des effets positifs directs sur la formation osseuse par l’activation de la prolifération, l’induction de la sécrétion de protéines de la matrice extracellulaire osseuse et la sécrétion de facteurs de croissance (insulin-like growth factor, transforming growt…”
BackgroundInfluentialHorner, K. C. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2745-1_15 · Cited by 2
Ogawa, M., Yokoo, S., Yamaguchi, T., Suzuki, K., & Makiguchi, T. (2019) · The Kitakanto Medical Journal · doi:10.2974/kmj.69.315 · Cited by 1
Rashad, N. M., El-Helaly, A. M., Radwan, A. M., & Ibrahim, N. F. (2021) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2021.144903 · Cited by 1
“stromal cell‐ and osteoblast‐ derived cytokines are under the control of sex hormones((7,8)), Bone resorption is reliant on receptor activator of the nuclear factor kappa B (NFκB) ligand (RANKL), a tumor necrosis factor (TNF) family member that is produced by osteoblasts, osteocytes, bone marrow stromal cells, and T-c…”
BackgroundReddy, S. V., & Roodman, G. D. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-736-9_14 · Cited by 1
Etiological factors of facial nerve stimulation in cochlear implant users
Евгеньевич, К. В., Сергеевич, Л. А., Борисовна, С. С., Tanaschishina, V. A., Дмитриевич, К. Д., Степанович, Л. Д., & Skirpichnikov, I. N. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-20-170-176 · Cited by 1
Silva, J. D. A., de Lima, C. A. D., Guaraná, W. L., Barbosa, A. D., Fragoso, T. S., Duarte, Â. L. B. P., Crovella, S., & Sandrin‐Garcia, P. (2023) · International Journal of Immunogenetics · doi:10.1111/iji.12613 · Cited by 1
“The lack of the hormone also decreases the number of osteoblasts and osteocytes, which impairs the detection of microdamage and immediate repair of bonemass (Pacifici, 1996; Rahnama et al., 2013).”
BackgroundNutritional considerations for the prevention and treatment of postmenopausal osteoporosis
Grippe, K. M., & Ryan, V. A. (2020) · JAAPA · doi:10.1097/01.jaa.0000977512.83053.bf · Cited by 1
Otologic and Neurotologic Disorders in Pregnancy
Goldrich, D. Y., Barishansky, S. J., & Wackym, P. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-36490-7_30 · Cited by 2
Hormone Replacement for Prevention and Treatment of Osteoporosis
Zochling, J., & Sambrook, P. N. (2000) · Endocrine updates · doi:10.1007/978-1-4757-6507-6_2 · Cited by 1
Type 2 diabetes exacerbates bone loss in Native American women
Leyva, M. J. (2012) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University) · Cited by 1
Osteoclast-forming Activity of Vascular Endothelial Growth Factor
Niida, S. (2005) · Journal of Oral Biosciences · doi:10.1016/s1349-0079(05)80018-0 · Cited by 1
González, Á. A. A. (2003) · Rehabilitación · doi:10.1016/s0048-7120(03)73389-1 · Cited by 1
Mattila, P. T. (1999) · Cited by 9
Regulation of Bone Cell Function by Estrogens
Komm, B. S., Cheskis, B. J., & Bodine, P. V. N. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50016-1 · Cited by 7
Pathophysiology and Aging of Bone
Pietschmann, P., Gruber, R., & Peterlik, M. (2003) · Medical radiology · doi:10.1007/978-3-662-05235-8_1 · Cited by 1
Estrogen-dependent Bone Loss and Osteoporosis
Lindsay, R. S., & Cosman, F. (2003) · doi:10.1007/978-1-4757-4561-0_9 · Cited by 1
Hadley, K. (2010) · Open University of Cape Town (University of Cape Town) · Cited by 2
Calcium-sensing Receptor in Bone
Yamaguchi, T. (2003) · Endocrine updates · doi:10.1007/978-1-4419-9256-7_5
Mechanisms of Estrogen Regulation of Bone Turnover and Bone Mass
Riggs, B. L. (2002) · Medical science symposia series · doi:10.1007/978-1-4615-1061-1_3
Marques, M. R. (2004) · doi:10.47749/t/unicamp.2004.302722 · Cited by 1
Development, characterization and imaging of bone metastasis mouse models -
Strube, A. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-13210
Immune regulation by selective estrogen receptor modulators
Bernardi, A. I. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Escolano, E. M. R. (2008) · Institutional Repository of the University of Granada (University of Granada)
Condi, F. L. D. F. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-26012012-102234 · Cited by 1
Ovarialhormone und Osteoporoseprophylaxe
Metka, M. (1997) · Der Gynäkologe · doi:10.1007/s001290050162
Combined continuous hormone replacement therapy: an update
Udoff, L. C., & Adashi, E. Y. (1997) · Reproductive Medicine Review · doi:10.1017/s096227990000137x
Osteopenia and osteoporosis in HIV-infected patients
Gołaszewska, D., & Racewicz, A. J. (2007) · HIV & AIDS Review · doi:10.1016/s1730-1270(10)60072-0
de Vernejoul, M. C., Cohen-Solal, M. E., & Bénichou, O. (2000) · Revue du Rhumatisme · doi:10.1016/s1169-8330(00)80055-1 · Cited by 1
Medema-Johnson, H. C., Janz, K. F., McGannon, K. R., Burns, T. L., Schlechte, J., & Snetselaar, L. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000403114.29138.56 · Cited by 1
“These factors indicate the role of reduced estrogen levels in the loss of bone strength and increased risk of OP among peri- and postmenopausal women (Pacifici, 1996).”
BackgroundMuscle to bone relationship in the forearm at midlife
Lorbergs, A. L. (2009) · University Library - University of Saskatchewan (University of Saskatchewan)
Johnston, B. D. (2015) · Brock University Digital Repository (Brock University)
Kaufman, B. C. (2008) · University of Minnesota Digital Conservancy (University of Minnesota)
Neuerburg, T. E. A. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5392 · Cited by 3
Physiological Disturbances in Postmenopausal Women
AL-Watify, D. G. O. (2014) · Journal of University of Babylon for Pure and Applied Sciences
Classical and paradoxical effects ofTNF-a on bone homeostasis
Miossec, P., Murakami, M., Kamimura, D., & Velard, F. (2014) · Cited by 1
Absorption in Health and Disease
Suzuki, Y., Landowski, C. P., & Hediger, M. A. (2008)
Importancia de la sintasas del óxido nítrico en el metabolismo del hueso
Valdez-Mijares, R., Franco-Bourland, R. E., Quintana-Armenta, A., & Ruíz-Rosano, L. (2012) · Revista Médica de la Universidad Veracruzana
Clément-Demange, L. (2015) · theses.fr (ABES) · doi:10.70675/f8ea456fza28ez4c4ez9d34z17f7e3a82b78
“De plus les œstrogènes possèdent également des effets anti-résorptifs indirects en inhibant la production de cytokines proostéoclastiques tels que l'IL1 (interleukine 1), l'IL6 (interleukine 6) et le TNFα (tumor necrosis factor α) (Pacifici, 1996).”
BackgroundFitoterapia aplicada ao tratamento da osteoporose
Catarino, R. S. M. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Adseverin is a Key Regulator and Marker of Osteoclastogenesis
Hassanpour, S. (2010) · TSpace (University of Toronto)
Childress, P. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2101
Endokrinologie, A. D. A., & Wuttke, W. (2011)
Association between TGF-β1 +869C/T polymorphism and fracture risk: a meta-analysis.
Zhang, Z., He, N., & Zhang, T. (2014) · PubMed
Zochling, J., & Sambrook, P. (2000)
Cell–Cell and Cell–Matrix Interactions in Bone
Bonewald, L. F. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50703-8
Deyama, Y., Takeyama, S., Yoshimura, Y., Nishikata, M., & Suzuki, K. (2001) · 歯科薬物療法 · doi:10.11263/jsotp1982.20.130
Trebec‐Reynolds, D. P. (2010) · TSpace (University of Toronto)
Osteoporosis in steroid-dependent asthma patients in Mosul
Hammo, W. M., Ahmad, M. M., Al-Habbo, D. J. S., & Al-Saegh, T. M. (2012) · Annals of the College of Medicine Mosul/Annals of the College of Medecine · doi:10.33899/mmed.2012.64602
Functional characterisation of an osteoclast-derived osteoblastic factor (ODOF)
Phan, T. A. (2004) · UWA Profiles and Research Repository (UWA) · Cited by 2
Semeghini, M. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.58.2017.tde-20032015-083227
Tartaroti, N. C. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.23.2016.tde-12062017-164715
de Azevedo, F. G. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.58.2014.tde-03022015-114733
Pathogenesis of Inflammation-Induced Bone Loss
Humphrey, M. B., & Nakamura, M. C. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-03437-1.50032-4
Metadata
- Authors
- Pacifici, R.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Pacifici, Roberto
- ORCID
- Pacifici, Roberto
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-08-01
- Volume
- 11
- Issue
- 8
- Pages
- 1043-1051
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2110993073
- Cited by
- 741
- References
- 90
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 15 · 2023: 20 · 2022: 20 · 2021: 24 · 2020: 20 · 2019: 26 · 2018: 30 · 2017: 15 · 2016: 19 · 2015: 31 · 2014: 29 · 2013: 22 · 2012: 28
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag013534-04)
- National Institute on Aging (AG 13534)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR041412, AR41412)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- postmenopausal osteoporosis, estrogen deficiency, cytokines, interleukin-1, TNF-α, bone resorption, osteoclastogenesis, osteoclast apoptosis, bone marrow, cytokine synergy, estrogen withdrawal, cytokine inhibitors
- MeSH terms
- Animals, Bone and Bones, Bone Resorption, Estrogens, Female, Humans, Menopause, Osteoporosis, Postmenopausal, Estrogen Replacement Therapy, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.